Re: Digest Number 1684
Former Trout <[email protected]> Thu, 24 May 2007 16:30:41 -0700 (PDT)
| Newsgroups | gmane.games.diplomacy.cat23.all-chat |
|---|---|
| Message-ID | <[email protected]> |
--pYqSmd6nGbgyRtcNN3IVo7KtIxuNMcrBmaroi1C Content-Type: text/plain; charset=US-ASCII Content-Transfer-Encoding: 7bit Hi David, There is a database in the Cat23-1200 group, I can attest to this as I just added game 1257 to it. There is also the game number database in the NGame group, but once a new game is entered you cannot seem to edit it unless you're a group moderator. (I think.. There's no option for me to edit it, at any rate.) Trout ----- Original Message ---- From: David E. Cohen <[email protected]> To: [email protected] Sent: Thursday, May 24, 2007 5:13:50 PM Subject: Re: [CAT23-Achat] Digest Number 1684 There is no database for this in the 1200 yahoogroup, or any other regular yahoogroup, as far as I know. There is a database maintained by David Watson, though I can't seem to locate the web address right now. End of Game Procedure Posted by: "Former Trout" [email protected] former.trout Tue May 22, 2007 11:51 pm (PST) Okay. I do have one question to throw out there. What are the hoops to jump through once one of your games ends? After posting the results, informing the players, opening the door to EOG summaries and updating the database on the Cat23-1200 group is there anything else to do? Is there anybody I should email to notify them of the game end? Thanks guys, Trout. </body> <!--~-|**|PrettyHtmlStart|**|-~--> <head> <style type="text/css"> <!-- #ygrp-mlmsg {font-size:13px; font-family: arial,helvetica,clean,sans-serif;*font-size:small;*font:x-small;} #ygrp-mlmsg table {font-size:inherit;font:100%;} #ygrp-mlmsg select, input, textarea {font:99% arial,helvetica,clean,sans-serif;} #ygrp-mlmsg pre, code {font:115% monospace;*font-size:100%;} #ygrp-mlmsg * {line-height:1.22em;} #ygrp-text{ font-family: Georgia; } #ygrp-text p{ margin: 0 0 1em 0; } #ygrp-tpmsgs{ font-family: Arial; clear: both; } #ygrp-vitnav{ padding-top: 10px; font-family: Verdana; font-size: 77%; margin: 0; } #ygrp-vitnav a{ padding: 0 1px; } #ygrp-actbar{ clear: both; margin: 25px 0; white-space:nowrap; color: #666; text-align: right; } #ygrp-actbar .left{ float: left; white-space:nowrap; } .bld{font-weight:bold;} #ygrp-grft{ font-family: Verdana; font-size: 77%; padding: 15px 0; } #ygrp-ft{ font-family: verdana; font-size: 77%; border-top: 1px solid #666; padding: 5px 0; } #ygrp-mlmsg #logo{ padding-bottom: 10px; } #ygrp-vital{ background-color: #e0ecee; margin-bottom: 20px; padding: 2px 0 8px 8px; } #ygrp-vital #vithd{ font-size: 77%; font-family: Verdana; font-weight: bold; color: #333; text-transform: uppercase; } #ygrp-vital ul{ padding: 0; margin: 2px 0; } #ygrp-vital ul li{ list-style-type: none; clear: both; border: 1px solid #e0ecee; } #ygrp-vital ul li .ct{ font-weight: bold; color: #ff7900; float: right; width: 2em; text-align:right; padding-right: .5em; } #ygrp-vital ul li .cat{ font-weight: bold; } #ygrp-vital a { text-decoration: none; } #ygrp-vital a:hover{ text-decoration: underline; } #ygrp-sponsor #hd{ color: #999; font-size: 77%; } #ygrp-sponsor #ov{ padding: 6px 13px; background-color: #e0ecee; margin-bottom: 20px; } #ygrp-sponsor #ov ul{ padding: 0 0 0 8px; margin: 0; } #ygrp-sponsor #ov li{ list-style-type: square; padding: 6px 0; font-size: 77%; } #ygrp-sponsor #ov li a{ text-decoration: none; font-size: 130%; } #ygrp-sponsor #nc { background-color: #eee; margin-bottom: 20px; padding: 0 8px; } #ygrp-sponsor .ad{ padding: 8px 0; } #ygrp-sponsor .ad #hd1{ font-family: Arial; font-weight: bold; color: #628c2a; font-size: 100%; line-height: 122%; } #ygrp-sponsor .ad a{ text-decoration: none; } #ygrp-sponsor .ad a:hover{ text-decoration: underline; } #ygrp-sponsor .ad p{ margin: 0; } o {font-size: 0; } .MsoNormal { margin: 0 0 0 0; } #ygrp-text tt{ font-size: 120%; } blockquote{margin: 0 0 0 4px;} .replbq {margin:4} --> </style> </head> <!--~-|**|PrettyHtmlEnd|**|-~--> </html><!--End group email --> --pYqSmd6nGbgyRtcNN3IVo7KtIxuNMcrBmaroi1C--